Orozco CJ, Hernández‑Mercado MA, Victoria Campos JL, Morales‑Bernal NE

Language: English
References: 19
Page: 114-118
PDF size: 241.90 Kb.

ABSTRACT

Multisite artery disease (MSAD) is common in patients with atherosclerosis involvement in one vascular bed, including the coronary arteries. The clinical presentation depends on the site and the severity of affected vascular territory as well as the time of disease developed. The therapeutic approach includes addressing the specific symptoms of any affected location and evaluates the risk associated with a specific lesion, in addition to manages the implementation in order to control cardiovascular (CV) risk factors. We present an unusual case of a patient with unstable angina and total obstruction of the vascular accesses (radial and femoral) that precluded the percutaneous coronary revascularization. Subsequently, through non-invasive CV imaging, the possibility of coronary artery bypass grafting (CABG) surgery was ruled out as there were no revascularizable coronary anatomy due to severe and diffuse atherosclerotic disease in coronary arteries.

REFERENCES

1. Aboyans V, Ricco JB, Bartelink MLE, Björck M, Brodmann M, Cohnert T et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017; 39 (9): 763-816.

2. Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diab Car. 2001; 24 (8): 1433-1437.

3. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015; 116 (9): 1509-1526.

4. Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008; 300 (2): 197-208.

5. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016; 37 (29): 2315-2381.

6. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016; 37 (3): 267-315.

7. Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. JACC. 2014; 64 (24): e139-e228.

8. Savji N, Rockman CB, Skolnick AH, Guo Y, Adelman MA, Riles T et al. Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects. JACC. 2013; 61 (16): 1736-1743.

9. Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013; 382 (9901): 1329-1340.

10. Jeremias A, Gruberg L, Patel J, Connors G, Brown DL. Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. JACC. 2010; 105 (9): 1268-1271.

11. Morillas P, Quiles J, Cordero A, Guindo J, Soria F, Mazón P et al. Prevalence of peripheral arterial disease in patients with acute coronary syndrome (PAMISCA) investigators. Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome. Am J Cardiol. 2009; 104 (11): 1494-1498.

12. Subherwal S, Bhatt DL, Li S, Wang TY, Thomas L, Alexander KP et al. Polyvascular disease and long-term cardiovascular outcomes in older patients with non–ST-segment–elevation myocardial infarction. Circ Cardiovasc Qual Out. 2012; 5 (4): 541-549.

13. Collet JP, Cayla G, Ennezat PV, Leclercq F, Cuisset T, Elhadad S et al. Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: the randomized AMERICA Study. Inter J Car. 2018; 54: 36-42.

14. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. New Eng J Med. 1996; 335 (18): 1342-1349.

15. Dencker D, Pedersen F, Engstrøm T, Køber L, Højberg S, Nielsen MB et al. Major femoral vascular access complications after coronary diagnostic and interventional procedures: a Danish register study. Inter J Car. 2016; 202: 604-608.

16. Farooq V, Serruys PW, Garcia-Garcia HM, Zhang Y, Bourantas CV, Holmes DR et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. JACC. 2013; 61 (3): 282-294.

17. Williams B, Menon M, Satran D, Hayward D, Hodges JS, Burke MN et al. Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality. Cath Cardiovasc Interv. 2010; 75 (6): 886-891.

18. Henry TD, Satran D, Hodges JS, Johnson RK, Poulose AK, Campbell AR et al. Long-term survival in patients with refractory angina. Eur Heart J. 2013; 34 (34): 2683-2688.

19. Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010; 121 (6): 750-758.